Icon

SYNTHROID (nda021402)- (0.025MG,0.025MG,0.05MG,0.05MG,0.075MG,0.075MG,0.088MG,0.088MG,0.1MG,0.1MG,0.112MG,0.112MG,0.125MG,0.125MG,0.137MG,0.137MG,0.15MG,0.15MG,0.175MG,0.175MG,0.2MG,0.2MG,0.3MG,0.3MG)

LEVOTHYROXINE SODIUM ABBVIE
0.025MG,0.025MG,0.05MG,0.05MG,0.075MG,0.075MG,0.088MG,0.088MG,0.1MG,0.1MG,0.112MG,0.112MG,0.125MG,0.125MG,0.137MG,0.137MG,0.15MG,0.15MG,0.175MG,0.175MG,0.2MG,0.2MG,0.3MG,0.3MG
No Yes
Expired Expired
None None
None No
SYNTHROID is a L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: • Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. • Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
0 0 0
Total Other Developers 40
Drugs with Suitability No
0.025MG ** ** - - -
0.05MG ** ** Up - -
0.075MG ** ** Up - -
0.088MG ** ** - - -
0.1MG ** ** - - -
0.112MG ** ** Up - -
0.125MG ** ** Up - -
0.137MG ** ** Up - -
0.15MG ** ** Up - -
0.175MG ** ** Up - -
0.2MG ** ** Up - -
0.3MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.